ICD-10-CM/PCS MS-DRG v38.1 Definitions Manual |
||||
Skip to content |
MDC 23 Factors influencing health status and other contacts with health services |
Other factors influencing health status |
Page 1 of 4 |
DRG |
---|
951 |
DRG 951 OTHER FACTORS INFLUENCING HEALTH STATUS
PRINCIPAL DIAGNOSIS
F17200 | Nicotine dependence, unspecified, uncomplicated |
F17201 | Nicotine dependence, unspecified, in remission |
F17210 | Nicotine dependence, cigarettes, uncomplicated |
F17211 | Nicotine dependence, cigarettes, in remission |
F17220 | Nicotine dependence, chewing tobacco, uncomplicated |
F17221 | Nicotine dependence, chewing tobacco, in remission |
F17290 | Nicotine dependence, other tobacco product, uncomplicated |
F17291 | Nicotine dependence, other tobacco product, in remission |
J95850 | Mechanical complication of respirator |
P002 | Newborn affected by maternal infectious and parasitic diseases |
P0089 | Newborn affected by other maternal conditions |
Q899 | Congenital malformation, unspecified |
Q920 | Whole chromosome trisomy, nonmosaicism (meiotic nondisjunction) |
Q921 | Whole chromosome trisomy, mosaicism (mitotic nondisjunction) |
Q922 | Partial trisomy |
Q925 | Duplications with other complex rearrangements |
Q9261 | Marker chromosomes in normal individual |
Q9262 | Marker chromosomes in abnormal individual |
Q927 | Triploidy and polyploidy |
Q928 | Other specified trisomies and partial trisomies of autosomes |
Q929 | Trisomy and partial trisomy of autosomes, unspecified |
Q930 | Whole chromosome monosomy, nonmosaicism (meiotic nondisjunction) |
Q931 | Whole chromosome monosomy, mosaicism (mitotic nondisjunction) |
Q932 | Chromosome replaced with ring, dicentric or isochromosome |
Q950 | Balanced translocation and insertion in normal individual |
Q951 | Chromosome inversion in normal individual |
Q952 | Balanced autosomal rearrangement in abnormal individual |
Q953 | Balanced sex/autosomal rearrangement in abnormal individual |
Q955 | Individual with autosomal fragile site |
Q958 | Other balanced rearrangements and structural markers |
Q959 | Balanced rearrangement and structural marker, unspecified |
Q999 | Chromosomal abnormality, unspecified |
R29700 | NIHSS score 0 |
R29701 | NIHSS score 1 |
R29702 | NIHSS score 2 |
R29703 | NIHSS score 3 |
R29704 | NIHSS score 4 |
R29705 | NIHSS score 5 |
R29706 | NIHSS score 6 |
R29707 | NIHSS score 7 |
R29708 | NIHSS score 8 |
R29709 | NIHSS score 9 |
R29710 | NIHSS score 10 |
R29711 | NIHSS score 11 |
R29712 | NIHSS score 12 |
R29713 | NIHSS score 13 |
R29714 | NIHSS score 14 |
R29715 | NIHSS score 15 |
R29716 | NIHSS score 16 |
R29717 | NIHSS score 17 |
R29718 | NIHSS score 18 |
R29719 | NIHSS score 19 |
R29720 | NIHSS score 20 |
R29721 | NIHSS score 21 |
R29722 | NIHSS score 22 |
R29723 | NIHSS score 23 |
R29724 | NIHSS score 24 |
R29725 | NIHSS score 25 |
R29726 | NIHSS score 26 |
R29727 | NIHSS score 27 |
R29728 | NIHSS score 28 |
R29729 | NIHSS score 29 |
R29730 | NIHSS score 30 |
R29731 | NIHSS score 31 |
R29732 | NIHSS score 32 |
R29733 | NIHSS score 33 |
R29734 | NIHSS score 34 |
R29735 | NIHSS score 35 |
R29736 | NIHSS score 36 |
R29737 | NIHSS score 37 |
R29738 | NIHSS score 38 |
R29739 | NIHSS score 39 |
R29740 | NIHSS score 40 |
R29741 | NIHSS score 41 |
R29742 | NIHSS score 42 |
R402130 | Coma scale, eyes open, to sound, unspecified time |
R402131 | Coma scale, eyes open, to sound, in the field [EMT or ambulance] |
R402132 | Coma scale, eyes open, to sound, at arrival to emergency department |
R402133 | Coma scale, eyes open, to sound, at hospital admission |
R402134 | Coma scale, eyes open, to sound, 24 hours or more after hospital admission |
R402140 | Coma scale, eyes open, spontaneous, unspecified time |
R402141 | Coma scale, eyes open, spontaneous, in the field [EMT or ambulance] |
R402142 | Coma scale, eyes open, spontaneous, at arrival to emergency department |
R402143 | Coma scale, eyes open, spontaneous, at hospital admission |
R402144 | Coma scale, eyes open, spontaneous, 24 hours or more after hospital admission |
R402230 | Coma scale, best verbal response, inappropriate words, unspecified time |
R402231 | Coma scale, best verbal response, inappropriate words, in the field [EMT or ambulance] |
R402232 | Coma scale, best verbal response, inappropriate words, at arrival to emergency department |
R402233 | Coma scale, best verbal response, inappropriate words, at hospital admission |
R402234 | Coma scale, best verbal response, inappropriate words, 24 hours or more after hospital admission |
R402240 | Coma scale, best verbal response, confused conversation, unspecified time |
R402241 | Coma scale, best verbal response, confused conversation, in the field [EMT or ambulance] |
R402242 | Coma scale, best verbal response, confused conversation, at arrival to emergency department |
R402243 | Coma scale, best verbal response, confused conversation, at hospital admission |
R402244 | Coma scale, best verbal response, confused conversation, 24 hours or more after hospital admission |
R402250 | Coma scale, best verbal response, oriented, unspecified time |
R402251 | Coma scale, best verbal response, oriented, in the field [EMT or ambulance] |
R402252 | Coma scale, best verbal response, oriented, at arrival to emergency department |
R402253 | Coma scale, best verbal response, oriented, at hospital admission |
R402254 | Coma scale, best verbal response, oriented, 24 hours or more after hospital admission |
R402330 | Coma scale, best motor response, abnormal flexion, unspecified time |
R402331 | Coma scale, best motor response, abnormal flexion, in the field [EMT or ambulance] |
R402332 | Coma scale, best motor response, abnormal flexion, at arrival to emergency department |
R402333 | Coma scale, best motor response, abnormal flexion, at hospital admission |
R402334 | Coma scale, best motor response, abnormal flexion, 24 hours or more after hospital admission |
R402350 | Coma scale, best motor response, localizes pain, unspecified time |
R402351 | Coma scale, best motor response, localizes pain, in the field [EMT or ambulance] |
R402352 | Coma scale, best motor response, localizes pain, at arrival to emergency department |
R402353 | Coma scale, best motor response, localizes pain, at hospital admission |
R402354 | Coma scale, best motor response, localizes pain, 24 hours or more after hospital admission |
R402360 | Coma scale, best motor response, obeys commands, unspecified time |
R402361 | Coma scale, best motor response, obeys commands, in the field [EMT or ambulance] |
R402362 | Coma scale, best motor response, obeys commands, at arrival to emergency department |
R402363 | Coma scale, best motor response, obeys commands, at hospital admission |
R402364 | Coma scale, best motor response, obeys commands, 24 hours or more after hospital admission |
R402410 | Glasgow coma scale score 13-15, unspecified time |
R402411 | Glasgow coma scale score 13-15, in the field [EMT or ambulance] |
R402412 | Glasgow coma scale score 13-15, at arrival to emergency department |
R402413 | Glasgow coma scale score 13-15, at hospital admission |
R402414 | Glasgow coma scale score 13-15, 24 hours or more after hospital admission |
R402420 | Glasgow coma scale score 9-12, unspecified time |
R402421 | Glasgow coma scale score 9-12, in the field [EMT or ambulance] |
R402422 | Glasgow coma scale score 9-12, at arrival to emergency department |
R402423 | Glasgow coma scale score 9-12, at hospital admission |
R402424 | Glasgow coma scale score 9-12, 24 hours or more after hospital admission |
R402430 | Glasgow coma scale score 3-8, unspecified time |
R402431 | Glasgow coma scale score 3-8, in the field [EMT or ambulance] |
R402432 | Glasgow coma scale score 3-8, at arrival to emergency department |
R402433 | Glasgow coma scale score 3-8, at hospital admission |
R402434 | Glasgow coma scale score 3-8, 24 hours or more after hospital admission |
R402440 | Other coma, without documented Glasgow coma scale score, or with partial score reported, unspecified time |
R402441 | Other coma, without documented Glasgow coma scale score, or with partial score reported, in the field [EMT or ambulance] |
R402442 | Other coma, without documented Glasgow coma scale score, or with partial score reported, at arrival to emergency department |
R402443 | Other coma, without documented Glasgow coma scale score, or with partial score reported, at hospital admission |
R402444 | Other coma, without documented Glasgow coma scale score, or with partial score reported, 24 hours or more after hospital admission |
R4183 | Borderline intellectual functioning |
R448 | Other symptoms and signs involving general sensations and perceptions |
R449 | Unspecified symptoms and signs involving general sensations and perceptions |
R45850 | Homicidal ideations |
R460 | Very low level of personal hygiene |
R461 | Bizarre personal appearance |
R462 | Strange and inexplicable behavior |
R463 | Overactivity |
R464 | Slowness and poor responsiveness |
R465 | Suspiciousness and marked evasiveness |
R466 | Undue concern and preoccupation with stressful events |
R467 | Verbosity and circumstantial detail obscuring reason for contact |
R4681 | Obsessive-compulsive behavior |
R4689 | Other symptoms and signs involving appearance and behavior |
R6813 | Apparent life threatening event in infant (ALTE) |
R6819 | Other nonspecific symptoms peculiar to infancy |
R6882 | Decreased libido |
R69 | Illness, unspecified |
R99 | Ill-defined and unknown cause of mortality |
T360X6A | Underdosing of penicillins, initial encounter |
T361X6A | Underdosing of cephalosporins and other beta-lactam antibiotics, initial encounter |
T362X6A | Underdosing of chloramphenicol group, initial encounter |
T363X6A | Underdosing of macrolides, initial encounter |
T364X6A | Underdosing of tetracyclines, initial encounter |
T365X6A | Underdosing of aminoglycosides, initial encounter |
T366X6A | Underdosing of rifampicins, initial encounter |
T367X6A | Underdosing of antifungal antibiotics, systemically used, initial encounter |
T368X6A | Underdosing of other systemic antibiotics, initial encounter |
T3696XA | Underdosing of unspecified systemic antibiotic, initial encounter |
T370X6A | Underdosing of sulfonamides, initial encounter |
T371X6A | Underdosing of antimycobacterial drugs, initial encounter |
T372X6A | Underdosing of antimalarials and drugs acting on other blood protozoa, initial encounter |
T373X6A | Underdosing of other antiprotozoal drugs, initial encounter |
T374X6A | Underdosing of anthelminthics, initial encounter |
T375X6A | Underdosing of antiviral drugs, initial encounter |
T378X6A | Underdosing of other specified systemic anti-infectives and antiparasitics, initial encounter |
T3796XA | Underdosing of unspecified systemic anti-infectives and antiparasitics, initial encounter |
T380X6A | Underdosing of glucocorticoids and synthetic analogues, initial encounter |
T381X6A | Underdosing of thyroid hormones and substitutes, initial encounter |
T382X6A | Underdosing of antithyroid drugs, initial encounter |
T383X6A | Underdosing of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter |
T384X6A | Underdosing of oral contraceptives, initial encounter |
T385X6A | Underdosing of other estrogens and progestogens, initial encounter |
T386X6A | Underdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter |
T387X6A | Underdosing of androgens and anabolic congeners, initial encounter |
T38806A | Underdosing of unspecified hormones and synthetic substitutes, initial encounter |
T38816A | Underdosing of anterior pituitary [adenohypophyseal] hormones, initial encounter |
T38896A | Underdosing of other hormones and synthetic substitutes, initial encounter |
T38906A | Underdosing of unspecified hormone antagonists, initial encounter |
T38996A | Underdosing of other hormone antagonists, initial encounter |
T39016A | Underdosing of aspirin, initial encounter |
T39096A | Underdosing of salicylates, initial encounter |
T391X6A | Underdosing of 4-Aminophenol derivatives, initial encounter |
T392X6A | Underdosing of pyrazolone derivatives, initial encounter |
T39316A | Underdosing of propionic acid derivatives, initial encounter |
T39396A | Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter |
T394X6A | Underdosing of antirheumatics, not elsewhere classified, initial encounter |
T398X6A | Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter |
T3996XA | Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter |
T400X6A | Underdosing of opium, initial encounter |
T402X6A | Underdosing of other opioids, initial encounter |
T403X6A | Underdosing of methadone, initial encounter |
T40416A | Underdosing of fentanyl or fentanyl analogs, initial encounter |
T40426A | Underdosing of tramadol, initial encounter |
T40496A | Underdosing of other synthetic narcotics, initial encounter |
T405X6A | Underdosing of cocaine, initial encounter |
T40606A | Underdosing of unspecified narcotics, initial encounter |
T40696A | Underdosing of other narcotics, initial encounter |
T407X6A | Underdosing of cannabis (derivatives), initial encounter |
T40906A | Underdosing of unspecified psychodysleptics [hallucinogens], initial encounter |
T40996A | Underdosing of other psychodysleptics [hallucinogens], initial encounter |
T410X6A | Underdosing of inhaled anesthetics, initial encounter |
T411X6A | Underdosing of intravenous anesthetics, initial encounter |
T41206A | Underdosing of unspecified general anesthetics, initial encounter |
T41296A | Underdosing of other general anesthetics, initial encounter |
T413X6A | Underdosing of local anesthetics, initial encounter |
T4146XA | Underdosing of unspecified anesthetics, initial encounter |
T415X6A | Underdosing of therapeutic gases, initial encounter |
T420X6A | Underdosing of hydantoin derivatives, initial encounter |
T421X6A | Underdosing of iminostilbenes, initial encounter |
T422X6A | Underdosing of succinimides and oxazolidinediones, initial encounter |
T423X6A | Underdosing of barbiturates, initial encounter |
T424X6A | Underdosing of benzodiazepines, initial encounter |
T425X6A | Underdosing of mixed antiepileptics, initial encounter |
T426X6A | Underdosing of other antiepileptic and sedative-hypnotic drugs, initial encounter |
T4276XA | Underdosing of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter |
T428X6A | Underdosing of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter |
T43016A | Underdosing of tricyclic antidepressants, initial encounter |
T43026A | Underdosing of tetracyclic antidepressants, initial encounter |
T431X6A | Underdosing of monoamine-oxidase-inhibitor antidepressants, initial encounter |
T43206A | Underdosing of unspecified antidepressants, initial encounter |
T43216A | Underdosing of selective serotonin and norepinephrine reuptake inhibitors, initial encounter |
T43226A | Underdosing of selective serotonin reuptake inhibitors, initial encounter |
T43296A | Underdosing of other antidepressants, initial encounter |
T433X6A | Underdosing of phenothiazine antipsychotics and neuroleptics, initial encounter |
T434X6A | Underdosing of butyrophenone and thiothixene neuroleptics, initial encounter |
T43506A | Underdosing of unspecified antipsychotics and neuroleptics, initial encounter |
T43596A | Underdosing of other antipsychotics and neuroleptics, initial encounter |
T43606A | Underdosing of unspecified psychostimulants, initial encounter |
T43616A | Underdosing of caffeine, initial encounter |
T43626A | Underdosing of amphetamines, initial encounter |
T43636A | Underdosing of methylphenidate, initial encounter |
T43696A | Underdosing of other psychostimulants, initial encounter |
T438X6A | Underdosing of other psychotropic drugs, initial encounter |
T4396XA | Underdosing of unspecified psychotropic drug, initial encounter |
T440X6A | Underdosing of anticholinesterase agents, initial encounter |
T441X6A | Underdosing of other parasympathomimetics [cholinergics], initial encounter |
T442X6A | Underdosing of ganglionic blocking drugs, initial encounter |
T443X6A | Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter |
T444X6A | Underdosing of predominantly alpha-adrenoreceptor agonists, initial encounter |
T445X6A | Underdosing of predominantly beta-adrenoreceptor agonists, initial encounter |
T446X6A | Underdosing of alpha-adrenoreceptor antagonists, initial encounter |
T447X6A | Underdosing of beta-adrenoreceptor antagonists, initial encounter |
T448X6A | Underdosing of centrally-acting and adrenergic-neuron-blocking agents, initial encounter |
T44906A | Underdosing of unspecified drugs primarily affecting the autonomic nervous system, initial encounter |
T44996A | Underdosing of other drug primarily affecting the autonomic nervous system, initial encounter |
T450X6A | Underdosing of antiallergic and antiemetic drugs, initial encounter |
T451X6A | Underdosing of antineoplastic and immunosuppressive drugs, initial encounter |
T452X6A | Underdosing of vitamins, initial encounter |
T453X6A | Underdosing of enzymes, initial encounter |
T454X6A | Underdosing of iron and its compounds, initial encounter |
T45516A | Underdosing of anticoagulants, initial encounter |
T45526A | Underdosing of antithrombotic drugs, initial encounter |
T45606A | Underdosing of unspecified fibrinolysis-affecting drugs, initial encounter |
T45616A | Underdosing of thrombolytic drugs, initial encounter |
T45626A | Underdosing of hemostatic drugs, initial encounter |
T45696A | Underdosing of other fibrinolysis-affecting drugs, initial encounter |
T457X6A | Underdosing of anticoagulant antagonist, vitamin K and other coagulants, initial encounter |
T458X6A | Underdosing of other primarily systemic and hematological agents, initial encounter |
T4596XA | Underdosing of unspecified primarily systemic and hematological agent, initial encounter |
T460X6A | Underdosing of cardiac-stimulant glycosides and drugs of similar action, initial encounter |
T461X6A | Underdosing of calcium-channel blockers, initial encounter |
T462X6A | Underdosing of other antidysrhythmic drugs, initial encounter |
T463X6A | Underdosing of coronary vasodilators, initial encounter |
T464X6A | Underdosing of angiotensin-converting-enzyme inhibitors, initial encounter |
T465X6A | Underdosing of other antihypertensive drugs, initial encounter |
T466X6A | Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter |
T467X6A | Underdosing of peripheral vasodilators, initial encounter |
T468X6A | Underdosing of antivaricose drugs, including sclerosing agents, initial encounter |
T46906A | Underdosing of unspecified agents primarily affecting the cardiovascular system, initial encounter |
T46996A | Underdosing of other agents primarily affecting the cardiovascular system, initial encounter |
T470X6A | Underdosing of histamine H2-receptor blockers, initial encounter |
T471X6A | Underdosing of other antacids and anti-gastric-secretion drugs, initial encounter |
T472X6A | Underdosing of stimulant laxatives, initial encounter |
T473X6A | Underdosing of saline and osmotic laxatives, initial encounter |
T474X6A | Underdosing of other laxatives, initial encounter |
T475X6A | Underdosing of digestants, initial encounter |
T476X6A | Underdosing of antidiarrheal drugs, initial encounter |
T477X6A | Underdosing of emetics, initial encounter |
T478X6A | Underdosing of other agents primarily affecting gastrointestinal system, initial encounter |
T4796XA | Underdosing of unspecified agents primarily affecting the gastrointestinal system, initial encounter |
T480X6A | Underdosing of oxytocic drugs, initial encounter |
T481X6A | Underdosing of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter |
T48206A | Underdosing of unspecified drugs acting on muscles, initial encounter |
T48296A | Underdosing of other drugs acting on muscles, initial encounter |
T483X6A | Underdosing of antitussives, initial encounter |
T484X6A | Underdosing of expectorants, initial encounter |
T485X6A | Underdosing of other anti-common-cold drugs, initial encounter |
T486X6A | Underdosing of antiasthmatics, initial encounter |
T48906A | Underdosing of unspecified agents primarily acting on the respiratory system, initial encounter |
T48996A | Underdosing of other agents primarily acting on the respiratory system, initial encounter |
T490X6A | Underdosing of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter |
T491X6A | Underdosing of antipruritics, initial encounter |
T492X6A | Underdosing of local astringents and local detergents, initial encounter |
T493X6A | Underdosing of emollients, demulcents and protectants, initial encounter |
T494X6A | Underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter |
T495X6A | Underdosing of ophthalmological drugs and preparations, initial encounter |
T496X6A | Underdosing of otorhinolaryngological drugs and preparations, initial encounter |
T497X6A | Underdosing of dental drugs, topically applied, initial encounter |
T498X6A | Underdosing of other topical agents, initial encounter |
T4996XA | Underdosing of unspecified topical agent, initial encounter |
T500X6A | Underdosing of mineralocorticoids and their antagonists, initial encounter |
T501X6A | Underdosing of loop [high-ceiling] diuretics, initial encounter |
T502X6A | Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter |
T503X6A | Underdosing of electrolytic, caloric and water-balance agents, initial encounter |
T504X6A | Underdosing of drugs affecting uric acid metabolism, initial encounter |
T505X6A | Underdosing of appetite depressants, initial encounter |
T506X6A | Underdosing of antidotes and chelating agents, initial encounter |
T507X6A | Underdosing of analeptics and opioid receptor antagonists, initial encounter |
T508X6A | Underdosing of diagnostic agents, initial encounter |
T50906A | Underdosing of unspecified drugs, medicaments and biological substances, initial encounter |
T50916A | Underdosing of multiple unspecified drugs, medicaments and biological substances, initial encounter |
T50996A | Underdosing of other drugs, medicaments and biological substances, initial encounter |
T50A16A | Underdosing of pertussis vaccine, including combinations with a pertussis component, initial encounter |
T50A26A | Underdosing of mixed bacterial vaccines without a pertussis component, initial encounter |
T50A96A | Underdosing of other bacterial vaccines, initial encounter |
T50B16A | Underdosing of smallpox vaccines, initial encounter |
T50B96A | Underdosing of other viral vaccines, initial encounter |
T50Z16A | Underdosing of immunoglobulin, initial encounter |
T50Z96A | Underdosing of other vaccines and biological substances, initial encounter |
Z0000 | Encounter for general adult medical examination without abnormal findings |
Z0001 | Encounter for general adult medical examination with abnormal findings |
Z00110 | Health examination for newborn under 8 days old |
Z00111 | Health examination for newborn 8 to 28 days old |
Z00121 | Encounter for routine child health examination with abnormal findings |
Z00129 | Encounter for routine child health examination without abnormal findings |
Z002 | Encounter for examination for period of rapid growth in childhood |
Z003 | Encounter for examination for adolescent development state |
Z005 | Encounter for examination of potential donor of organ and tissue |
Z006 | Encounter for examination for normal comparison and control in clinical research program |
Z0070 | Encounter for examination for period of delayed growth in childhood without abnormal findings |
Z0071 | Encounter for examination for period of delayed growth in childhood with abnormal findings |
Z008 | Encounter for other general examination |
Z0100 | Encounter for examination of eyes and vision without abnormal findings |
Z0101 | Encounter for examination of eyes and vision with abnormal findings |
Z01020 | Encounter for examination of eyes and vision following failed vision screening without abnormal findings |
Z01021 | Encounter for examination of eyes and vision following failed vision screening with abnormal findings |
Z0110 | Encounter for examination of ears and hearing without abnormal findings |
Z01110 | Encounter for hearing examination following failed hearing screening |
Z01118 | Encounter for examination of ears and hearing with other abnormal findings |
Z0112 | Encounter for hearing conservation and treatment |
Z0120 | Encounter for dental examination and cleaning without abnormal findings |
Z0121 | Encounter for dental examination and cleaning with abnormal findings |
Z0130 | Encounter for examination of blood pressure without abnormal findings |
Z0131 | Encounter for examination of blood pressure with abnormal findings |
Z01411 | Encounter for gynecological examination (general) (routine) with abnormal findings |
Z01419 | Encounter for gynecological examination (general) (routine) without abnormal findings |
Z0142 | Encounter for cervical smear to confirm findings of recent normal smear following initial abnormal smear |
Z01810 | Encounter for preprocedural cardiovascular examination |
Z01811 | Encounter for preprocedural respiratory examination |
Z01812 | Encounter for preprocedural laboratory examination |
Z01818 | Encounter for other preprocedural examination |
Z0182 | Encounter for allergy testing |
Z0183 | Encounter for blood typing |
Z0184 | Encounter for antibody response examination |
Z0189 | Encounter for other specified special examinations |
Z020 | Encounter for examination for admission to educational institution |
Z021 | Encounter for pre-employment examination |
Z022 | Encounter for examination for admission to residential institution |
Z023 | Encounter for examination for recruitment to armed forces |
Z024 | Encounter for examination for driving license |
Z025 | Encounter for examination for participation in sport |
Z026 | Encounter for examination for insurance purposes |
Z0271 | Encounter for disability determination |
Z0279 | Encounter for issue of other medical certificate |
Z0281 | Encounter for paternity testing |
Z0282 | Encounter for adoption services |
Z0283 | Encounter for blood-alcohol and blood-drug test |
Z0289 | Encounter for other administrative examinations |
Z029 | Encounter for administrative examinations, unspecified |
Z036 | Encounter for observation for suspected toxic effect from ingested substance ruled out |
Z0371 | Encounter for suspected problem with amniotic cavity and membrane ruled out |
Z0372 | Encounter for suspected placental problem ruled out |
Z0373 | Encounter for suspected fetal anomaly ruled out |
Z0374 | Encounter for suspected problem with fetal growth ruled out |
Z0375 | Encounter for suspected cervical shortening ruled out |
Z0379 | Encounter for other suspected maternal and fetal conditions ruled out |
Z03810 | Encounter for observation for suspected exposure to anthrax ruled out |
Z03818 | Encounter for observation for suspected exposure to other biological agents ruled out |
Z03821 | Encounter for observation for suspected ingested foreign body ruled out |
Z03822 | Encounter for observation for suspected aspirated (inhaled) foreign body ruled out |
Z03823 | Encounter for observation for suspected inserted (injected) foreign body ruled out |
Z0389 | Encounter for observation for other suspected diseases and conditions ruled out |
Z0441 | Encounter for examination and observation following alleged adult rape |
Z0442 | Encounter for examination and observation following alleged child rape |
Z046 | Encounter for general psychiatric examination, requested by authority |
Z0471 | Encounter for examination and observation following alleged adult physical abuse |
Z0472 | Encounter for examination and observation following alleged child physical abuse |
Z0481 | Encounter for examination and observation of victim following forced sexual exploitation |
Z0482 | Encounter for examination and observation of victim following forced labor exploitation |
Z0489 | Encounter for examination and observation for other specified reasons |
Z049 | Encounter for examination and observation for unspecified reason |
Centers for Medicare & Medicaid Services, 7500 Security Boulevard Baltimore, MD 21244 20 Nov 2020 15:32:59 CMS, code-revision=283, description-revision=1293 |